Clinical trial
A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age…
NCT00484003 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00484003 |
|---|---|
| Title | A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis |
| Official title | A 3-Month Open Label, National, Quality of Life , and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years ) With Atopic Dermatitis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Eczema |
| Intervention type | Drug |
| Interventions | Pimecrolimus cream 1% |
| Start date | Oct 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Jun 8, 2007 |
| Last update posted | Feb 15, 2008 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: